Differential activation and functional specialization of miR-146 and miR-155 in innate immune sensing by Schulte, Leon N. et al.
Differential activation and functional specialization
of miR-146 and miR-155 in innate immune sensing
Leon N. Schulte, Alexander J. Westermann and Jo¨rg Vogel*
RNA Biology Group, Institute for Molecular Infection Biology, University of Wu¨rzburg, Josef-Schneider Strasse
2/D15, D-97080 Wu¨rzburg, Germany
Received August 1, 2012; Revised October 2, 2012; Accepted October 4, 2012
ABSTRACT
Many microRNAs (miRNAs) are co-regulated during
the same physiological process but the underlying
cellular logic is often little understood. The con-
served, immunomodulatory miRNAs miR-146 and
miR-155, for instance, are co-induced in many cell
types in response to microbial lipopolysaccharide
(LPS) to feedback-repress LPS signalling through
Toll-like receptor TLR4. Here, we report that these
seemingly co-induced regulatory RNAs dramatically
differ in their induction behaviour under various
stimuli strengths and act non-redundantly through
functional specialization; although miR-146 expres-
sion saturates at sub-inflammatory doses of LPS
that do not trigger the messengers of inflammation
markers, miR-155 remains tightly associated with
the pro-inflammatory transcriptional programmes.
Consequently, we found that both miRNAs control
distinct mRNA target profiles; although miR-146
targets the messengers of LPS signal transduction
components and thus downregulates cellular LPS
sensitivity, miR-155 targets the mRNAs of genes
pervasively involved in pro-inflammatory transcrip-
tional programmes. Thus, miR-155 acts as a broad
limiter of pro-inflammatory gene expression once
the miR-146 dependent barrier to LPS triggered in-
flammation has been breached. Importantly, we also
report alternative miR-155 activation by the sensing
of bacterial peptidoglycan through cytoplasmic
NOD-like receptor, NOD2. We predict that dose-
dependent responses to environmental stimuli may
involve functional specialization of seemingly co-
induced miRNAs in other cellular circuitries as well.
INTRODUCTION
MicroRNAs (miRNAs) constitute an abundant class of
small non-coding RNAs of 22 nt in size that act as
post-transcriptional regulators of gene expression. A
single miRNA can modulate the expression of dozens of
mRNAs, typically through short seed pairing within the 30
untranslated region (UTR), leading to translational inhib-
ition and/or degradation of the targeted messenger (1). Of
the several hundred known miRNAs, many seem to have
partially overlapping functions because of the conservation
of the seed within a given miRNA family, and, therefore,
similar target profiles. Alternatively, evolutionary unre-
lated miRNAs may be activated by the same transcription
factor and thus overlap in their activity in a given cellular
pathway. Primary examples of the latter are miR-146 and
miR-155, both of which are activated in the antimicrobial
response of mammalian macrophages. Although mir-146
and miR-155 are each conserved in sequence down to the
bottom of the vertebrate lineage (2), they do not show
sequence similarity. Moreover, they arise from different
genomic loci through different routes of processing, that
is, from a pre-mRNA (miR-146a), an mRNA intron
(miR-146b) or an exon of a long non-coding RNA
(miR-155); yet, wherever studied, the synthesis of these
miRNAs has been observed to crucially depend on the
pro-inflammatory transcription factor NFkB (3–6).
The co-activation of miR-146 and miR-155 during the
inflammatory response was initially revealed in human
monocytes (3) through a seminal screen for miRNAs
that were regulated by the bacterial component, lipopoly-
saccharide (LPS), which is primarily sensed by Toll-like
receptor 4 (TLR4). Stimulation of TLR4 triggers the
nuclear translocation of NFkB, resulting in transcrip-
tional activation of NFkB target genes encoding various
mediators of inflammation, such as cytokines, acute phase
proteins and inducible enzymes (7). Subsequent findings
that both miR-146 and miR-155 targeted mRNAs in the
signalling cascade downstream of TLR4 bolstered the link
with NFkB-regulated innate immunity, leading to a model
in which these two miRNAs facilitate a negative-feedback
loop that may protect from an excessive TLR4 response.
The stimulation of TLR4 is signalled through two
parallel cascades beginning with the TLR adaptors,
MyD88 and TRIF, as reviewed by Akira and Takeda
(8), and both these branches contain targets of miR-146
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and miR-155. The MyD88-dependent cascade signals
through IRAK1 and TRAF6, which are targets of
miR-146 (3). Assisted by TAB2, which is regulated by
miR-155 (9), the MyD88 branch eventually activates the
IKK and MAPK pathways, resulting in nuclear transloca-
tion of NFkB and the activation of transcription factor
AP-1, respectively. Together, NFkB and AP-1 induce the
expression of major pro-inflammatory cytokines, such as
tumour necrosis factor (TNF)-a, which mediate autocrine/
paracrine amplification of the NFkB response through
TNF-receptor signalling. Through TRAF6, the MyD88
cascade also activates NIK kinase, thereby amplifying
the production of pro-inflammatory prostaglandins (10).
Finally, TRAF6 and TAB2 are crucial for an alternative
route of TLR4 signalling through TRIF, in which the in-
duction of the IRF3/7 transcription factors (through
TBK1 and IKKe) culminates in the production of type I
interferons. This bottom part of the cascade may also be
subject to feedback control by miRNA, as IKKe has been
predicted to be a target of miR-155 (11,12).
Although the above targets may favour a one-tier model
wherein the seemingly co-regulated miR-146 and miR-155
invariably act to feedback regulate TLR4 signalling, other
observations hint at more specialized functions. For
instance, miR-155 targets Ship-1, a negative modulator
of TLR signalling (13), and thus also increases TLR4
activity. Likewise, miR-155 stabilizes the mRNA of the
pro-inflammatory cytokine TNF-a, which will also
regulate the NFkB response (11,14). Phenotypic studies
have also indicated a potential specialization, suggesting
that miR-146 and miR-155 might control the inflamma-
tory response at distinct levels. That is, miR-155 knock-
out mice are unable to initiate an adaptive immune
response to Salmonella typhimurium, likely at the level of
dendritic cell function (15), arguing that miR-155 primar-
ily promotes pro-inflammatory responses. In contrast, sus-
tained miR-146 expression is critical for the maintenance
of innate immune tolerance in mice (16,17).
Here, we report on the dose-dependent activation of
miR-146 and miR-155 in macrophages in response to
several inflammatory stimuli. Surprisingly, we found dra-
matic differences in how LPS activated these two miRNAs,
showing that miR-146 is activated at sub-inflammatory
levels of NFkB activity, whereas miR-155 is gradually
induced to full expression at pro-inflammatory magnitudes
of NFkB activity. Accordingly, endotoxin-tolerant cells
with mute TLR-based immunity only activate miR-146
and not miR-155 to feedback regulate TLR signalling.
We also present the first evidence that cytosolic sensing of
microbial peptidoglycan by a NOD-like receptor (NLR)
can rescue activation of miR-155 through a TLR-
independent pathway. Moreover, we show that miR-155
represses the TNF-a autocrine/paracrine signal amplifica-
tion route, which is an integral part of the macrophage
pro-inflammatory response. Collectively these observations
suggest a general two-tier model in which miR-155 acts as a
stringent regulator of pro-inflammatory responses once an
miR-146-dependent barrier to TLR-induced inflammation
is breached. This provides a general example of the func-
tional specialization of seemingly co-induced miRNAs that
act in the same cellular pathway.
MATERIALS AND METHODS
Culture, stimulation and transfection of cells
Mouse embryonic fibroblast (MEF), RAW264.7 and
RAWBlueTM (Invivogen) cells were cultured in RPMI
1640 (Gibco), 10% of fetal bovine serum (Biochrom),
2mM of L-glutamine (Gibco), 1mM of sodium-pyruvate
(Gibco), 0.1% of b-mercapto-ethanol (Gibco), 1% of peni-
cillin/streptomycin solution (Gibco) at 37C, 5% of CO2 in
a humidified atmosphere. Endotoxin tolerance was induced
as described previously (25) but using LPS (1mg/ml) instead
of heat-killed Salmonella. For all purposes, cells were
seeded into 24-well plates (Corning) at a density of
5 104 cells per 0.5ml medium 2 days before further treat-
ment, if not specified differently. S. typhimurium LPS
(Sigma, # L6143), bacterial lipoprotein (BLP, Invovogen,
# tlrl-pms) and TNF-a (R&D, # 410-MT) were added
directly into the medium, whereas g-D-glutamyl-meso-
diaminopimelic acid (iE-DAP) (Invivogen, # tlrl-dap),
N-acetyl-muramyl-L-Ala-g-D-Glu-meso-diaminopimelic
acid (M-TriDAP) (Invivogen, # tlrl-mtd) and N-acetyl-
muramyl dipeptide (MDP) (Invivogen, #tlrl-mdp) were
transfected using lipofectamine 2000 (Invitrogen) according
to the manufacturer’s instructions. For co-stimulation, LPS
or TNF-a were added into the culture medium right on the
addition of the lipofection mix. For ectopic miRNA, expres-
sion cells were lipofected as aforementioned for 12h, with
Pre-miRTM synthetic precursor molecules (Ambion,
control: # AM17110, mmu-miR-146: equimolar mixture of
# PM10722 and # PM10105, mmu-miR-155: # PM13058)
24h on seeding. The same protocol was applied for inhib-
ition of miRNA activity using but LNATM antisense probes
instead (Exiqon, control: # 199004-08, miR-146: equimolar
mix of # 41063-08 and # 410066-08, miR-155: # 411222-08).
Luciferase reporter plasmids were transfected into MEF
cells 24h on seeding at 500ng per 24-well along with
the Pre-miRTM molecules as aforementioned using
lipofectamine 2000. On 12h of incubation, liposomes were
removed, and luciferase activities were determined another
24h later. RAW264.7 cells were transfected 24h on seeding
with 1mg of luciferase reporter plasmid per well using
lipofectamine 2000. After 12h of incubation, liposomes
were removed, and cells were allowed to recover from im-
munogenic side-effects of microbial plasmid DNA for 48h.
To prevent from growing too densely, cells were then
disattached and seeded into new 24-well plates, followed
by the routine 48h of incubation before further treatment.
Bone marrow-derived macrophages (BMDMs) were
generated from the bone marrow of female C57/BL6 mice.
Briefly, a bonemarrow suspension of 5 106 cells in 10ml of
BMDMmedium (X-Vivo 15, Lonza, # BE04-744Q, supple-
mented with 10% of FBS and 10% of L929 conditioned
medium) were seeded into 10-cm Petri dishes (Corning).
On incubation for 5 days, cells were seeded into 24-well
plates (2 105 cells per well) incubated for 48h and
treated with various doses of LPS for 8 h.
Reporter assays
RAWBlueTM NFkB-reporter activity was determined
colorimetrically using QuantiBlueTM reagent (Invivogen)
2 Nucleic Acids Research, 2012
according to the manufacturer’s instructions in transpar-
ent 96-well flat-bottom plates (Corning). The read-out was
performed at 630 nm on an Ascent Plate Reader (Thermo
Scientific).
30 UTR luciferase reporter assays were performed using
the pSICHECK2TM dual luciferase reporter system
(Promega). Cell lysates were generated using passive cell
lysis buffer (Promega) according to the manufacturer’s
instructions. Firefly and Renilla luciferase activities were
recorded on a Wallac 1420 Victor3 plate reader (Perkin
Elmer) in white non-transparent 96-well flat-bottom plates
(Perkin Elmer) using 40 ml pH 5 adjusted Beetle-juice (PJK
GmbH) followed by 40 ml Renilla-juice (PJK GmbH) per
well.
Real-time polymerase chain reaction
For real-time polymerase chain reaction (PCR) analysis,
cellular total RNA was extracted using TRIzol reagent
(Invitrogen). The messengers of Ptgs2, IL-6 and TNF-a
were detected using the Power SYBR Green RNA-to-
CTTM 1-Step kit (Applied Biosystems) and primer pairs
listed in Supplementary Table S1. b-Actin mRNA was
used as a normalization control and was detected with
the primer pair published in (18). Mature and primary
miRNA transcripts were detected using TaqManTM
pre-designed assay kits (Applied Biosystems, mature
miR-146a: # 000468, mature miR-146b: # 001097,
mature miR-155: # 001806, pri-miR-146a: #
Mm03306349_pri, pri-miR-146b: # Mm03308117_pri,
pri-miR-155: # Mm03306395_pri), with snoRNA202 (#
001232) as a normalization control according to the
manufacturer’s instructions. All real-time PCR experi-
ments were carried out on a Biorad CFX96 machine,
and fold changes in gene expression were deduced from
CT-values according to the 2(CT) method (19).
Cloning
For cloning of pSICHECK2TM (Promega) reporter con-
structs candidate, 30 UTRs were amplified from mouse
cDNA according to current ENSEMBL annotations,
using the primer pairs listed in Supplementary Table S1.
All UTRs were cloned using the XhoI and NotI restriction
sites of the pSICHECK2TM plasmid. Mutations were
introduced by mutagenesis PCR using the primer pairs
listed in Supplementary Table S1. Briefly, the respective
reporter plasmid was amplified by regular PCR (15 cycles)
using a primer pair with a 12–16-nt 50 overlap harbour-
ing the desired mutations. On incubation of the 50 ml
reaction mixture with 1 ml DpnI at 37C for 3 h, 5 ml was
transformed directly into competent Escherichia coli
TOP10. DNA sequences were validated by Sanger
sequencing (SMB services). All PCR reactions were
carried out with PhusionTM High-Fidelity DNA
Polymerase (Thermo Scientific) according to the manufac-
turer’s instructions. Endotoxin-free plasmid preparations
for eukaryotic cell culture were obtained using Highspeed
Maxi PrepTM kits (Qiagen) according to the manufac-
turer’s instructions.
Statistical tests
Observed differences between two treatments were tested
for significance using a two-tailed student’s t-test,
assuming either equal or different variances where appro-
priate. P values of <0.05 were considered as a measure for
statistical significance.
RESULTS
Primary association of BIC/miR-155 with inflammation
Previous studies assigned discrete functions to miR-146 and
miR-155, but the degree of co-regulation and potential re-
dundancy of these miRNAs in the LPS response remained
poorly understood. We determined the induction of the
primary and mature miR-146a, miR-146b and miR-155
transcripts by increasing LPS doses in a 0–1mM range in
RAW264.7 murine macrophages. As a positive control for
pro-inflammatory transcription, we also profiled the clas-
sical inflammation markers, Ptgs2, IL-6 and TNF-a; these
genes showed the expected gradual induction (20), reaching
high expression levels at 1mM of LPS (Figure 1A).
The same gradual increase that typically marks NFkB-
dependent transcription (21) was also observed for both
BIC, the host gene of miR-155 (Figure 1C) and the
mature miR-155 (Figure 1B), which tightly links miR-155
expression to the pro-inflammatory transcription pro-
gramme. In sharp contrast, the activation of miR-146a
and miR-146b not only saturated at much lower LPS
doses but also occurred in a narrow window between 0.1
and 1ng LPS per ml (Figure 1B); this regulation is likely to
be at the level of transcription because it is also observed at
the level of the primary miR-146 transcripts (Figure 1C).
Of note, these low concentrations of LPS only modestly
induce the inflammatory response (Figure 1A), suggesting
that miR-146 expression is exceptionally responsive to even
minute amounts of this TLR4 ligand.
To confirm that TLR4 indeed accounts for the differen-
tial induction of miR-146 and miR-155, we quantified
miRNA induction in wild-type and TLR4-deficient
murine BMDMs challenged with increasing doses of LPS.
Generally, the thresholds of miR-146 and miR-155 induc-
tion in response to LPS were lower in wild-type BMDMs
(Figure 2A) compared with RAW264.7 macrophages
(Figure 1), demonstrating that the exceptional sensitivity
of miR-146 to LPS is even more pronounced in primary
cells. Similar to RAW264.7 cells, however, miR-146a and
miR-146b were triggered at much lower concentrations of
LPS (0.1 ng LPS per ml) than miR-155 (saturating at 10ng
LPS per ml). In TLR4 deficient BMDMs (Figure 2B),
saturating miR-146a and miR-146b induction required a
100-fold increase of the LPS dose compared with
wild-type BMDMs, whereas miR-155 expression did not
reach saturation over the tested range. This argues that
the induction of miR-146 at minute concentrations of
LPS and the pronounced activation of miR-155 at high
concentrations are both mediated by TLR4. Next, we
determined the kinetics of induction of miR-146a/b and
miR-155 at a fixed concentration of 1mM LPS for 24h
in RAW264.7 macrophages and observed a full
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concordance with the time-dependent upregulation of
Ptgs2, IL-6 and TNF-a (Supplementary Figure S1). Thus,
irrespective of similar induction kinetics in macrophages
challenged with high LPS doses, miR-146 and miR-155
are in fact activated in a two-tier manner, responding to
sub-inflammatory (miR-146) and pro-inflammatory
(miR-155) levels of TLR4 stimulation, respectively.
Selective control of TNF-a signalling by miR-155
Given that only miR-155, and not miR-146, was
co-regulated with pro-inflammatory genes (Figure 1), we
hypothesized that miR-155 might specifically regulate a
signalling event that occurs after LPS sensing has
prompted NFkB translocation to the nucleus and has suc-
cessfully activated inflammatory gene transcription. A
candidate pathway was the autocrine/paracrine signalling
through TNF-a that serves to amplify or sustain NFkB
activity. To test this hypothesis, we transfected a
RAW264.7 macrophage clone harbouring an NFkB-
responsive secreted alkaline phosphatase reporter trans-
gene (RAWBlueTM) with synthetic miR-146 or miR-155
mimics, and monitored their impact on NFkB activity on
Figure 1. Expression analysis of inflammation markers and miRNAs in RAW264.7 macrophages challenged with the indicated doses of LPS (x-axis:
ng/ml) for 24 h. Expression of inflammation markers Ptgs2, IL-6 and TNF-a (A), mature miR-146a, miR-146b and miR-155 (B) and the primary
transcripts of miR-146a, miR-146b and miR-155 (C) was monitored by quantitative reverse transcriptase (qRT)-PCR. All results are presented as
fold-changes (y-axis) relative to 24 h control-treatment. Mean values and standard deviations from three independent experiments are shown.
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stimulation with TNF-a (0.2mM) or LPS (1mM). As
expected from previous reports (22), we observed that
both miR-146 and miR-155 were able to reduce LPS-
induced NFkB activity (Figure 3A). Importantly,
however, when TNF-a was used as a stimulus, only
miR-155 counteracted the upregulation of the NFkB
reporter gene (Figure 3B). In the converse approach,
that is, sequestration of the endogenous miRNAs with
locked nucleic acid (LNA)-based inhibitors, again both
miR-146 and miR-155 impacted NFkB activity after in-
duction with LPS (Figure 3C), whereas the stimulation
with TNF-a was selectively regulated by the miR-155 in-
hibitor (Figure 3D). In all of these cases, the simultaneous
over-expression or inhibition of miR-146 and miR-155
mimicked the phenotype of miR-155 alone, suggesting
that miR-155 acts upstream of miR-146 in the control of
NFkB activity. Taken together, in line with their expres-
sion dynamics, both miR-146 and miR-155 control the
primary TLR4-induced NFkB activation, whereas the
feedback control of subsequent paracrine/autocrine-
induced pro-inflammatory signalling through TNF-a is a
unique domain of miR-155.
Distinct target regulation of miR-155 and miR-146
in the LPS response
Next, to better understand the two-tier function of
miR-146 and miR-155 in murine macrophages, we
analysed their activity on key mRNA targets in the LPS
response (Figure 4). These targets included the TLR4
signalling components IRAK1 and TRAF6, which had
been predicted to be repressed by miR-146 to feedback
control the human TLR4 response (3); the general
signalling component TAB2, which controls multiple
branches of NFkB activating pathways, is regulated by
miR-155 (9) and IKKe, a predicted target of miR-155,
which mediates LPS-induced activation of type I
interferon (Figure 4A). As NIK kinase has been
implicated in TLR4 signalling downstream of IRAK1
(23), and it reportedly triggers the expression of key me-
diators of antimicrobial defence (10,24), we hypothesized
that it might be an miR-155 target as well. Indeed, a
manual search revealed a potential miR-155 binding site
in the 30 UTR of the NIK mRNA (Figure 4B), suggesting
that miR-155 ensures tight control of inflammatory gene
Figure 2. Expression analysis of mature miRNAs in wild-type and TLR4/ BMDMs challenged with the indicated doses of LPS (x-axis: ng/ml) for
8 h. Expression of mature miR-146a, miR-146b and miR-155 in wild-type BMDMs (A) or TLR4/ BMDMs (B) was monitored by qRT-PCR.
Results are presented as fold-changes (y-axis) relative to 8 h control-treatment. Mean values and standard deviations from three independent
experiments are shown.
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expression at multiple levels immune signalling triggered
by pathogen associated molecular patterns (PAMPs).
To validate these predicted points of regulation, the re-
spective mouse 30 UTRs were fused to a luciferase reporter
gene and tested for their sensitivity to miR-155 or
miR-146 in fibroblasts. In the case of miR-155, transfec-
tion of miRNA precursors resulted in significant
downmodulation of the NIK, IKKe and TAB2 reporters,
whereas miR-146 over-expression had no effect on these
constructs (Figure 4C). We consider the regulation to be
specific, as they were abrogated by the introduction of two
point mutations in the predicted miR-155 binding sites.
Vice versa, the TRAF6 and IRAK1 targets were specific-
ally regulated by miR-146, but not by miR-155
(Supplementary Figure S2), which supports the notion
that miR-146 and miR-155 have discrete target profiles.
To confirm the inflammation-specific regulation of
targets by miR-155, we tested the responsiveness of wild-
type and mutated miR-155 target reporters in RAW264.7
macrophages challenged with 0.1 ng or 1 mg of LPS. In line
with our miR-155 expression data (Figure 1), only the
pro-inflammatory (1 mg) and not the sub-inflammatory
(0.1 ng) dose of LPS resulted in specific repression of the
NIK, IKKe and TAB2 targets by the endogenous
miR-155 (Figure 4D). Collectively, these results suggest
that on pro-inflammatory stimulation of TLR4,
miR-155, rather than miR-146, acts pervasively to limit
the NFkB-dependent inflammatory response.
Figure 3. Analysis of NFkB reporter activity in RAWBlueTM macrophages on challenge with LPS or TNF-a and miRNA over-expression or
inhibition. Cells lipofected without or with synthetic control-miRNA precursors or miR-146 and miR-155 precursors were challenged with
1000 ng LPS/ml (A) or 200 ng TNF-a/ml (B), and fold-changes (y-axis) in NFkB reporter activity were calculated relative to non-challenged
controls. Cells lipofected without or with a control-inhibitor or miR-146- and miR-155-inhibitors were challenged with 1000 ng LPS/ml (C) or
200 ng TNF-a/ml (D), and fold-changes (y-axis) in reporter activity were calculated relative to non-challenged controls. Mean values and standard
deviations from three independent experiments are shown. Asterisks denote statistically significant regulation (P< 0.05) compared with the 3 or 5 nM
control (asterisk) and the 30 or 50 nM control (double asterisk), respectively.
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Figure 4. Analysis of 30 UTR luciferase reporters of known and putative miR-155 targets. (A) Schematic overview of miR-146 (blue) and miR-155
targets (red) in the macrophage LPS response. (B) RNAHybrid prediction of miR-155 binding within the 30 UTRs of murine TAB2, IKKe and NIK
mRNAs. Lines denote Watson–Crick base pairs, black dots denote wobble base pairs. Seed matches are highlighted in grey. Crosses denote
point-mutations (A!C and U!G) introduced to abrogate regulation. (C) Analysis of wild-type (wt) or miR-155 binding-site mutant (mut) 30
UTR reporters of NIK, IKKe and TAB2 in mouse embryonic fibroblasts lipofected with synthetic control-, miR-146a- or miR-155-precursors. (D)
Analysis of the same reporters as aforementioned in RAW264.7 macrophages, co-challenged with the indicated doses of LPS for 24 h. All results are
presented as fold-changes relative to control-precursor lipofection (y-axis). Mean values and standard deviations from three independent experiments
are shown. Asterisks denote statistically significant regulation (P< 0.05) comparing the indicated treatments.
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Opposite roles of miR-146 and miR-155 in endotoxin
tolerance
Given that miR-155 is a major regulator of pro-
inflammatory responses, we asked how its activation by
bacterial stimuli is ensured under conditions, when innate
immune sensing through TLR4 is mute. For example, we
recently discovered that macrophages brought into an
endotoxin-tolerant state by previous exposure to LPS
barely induce miR-155 and other inflammation markers
when challenged with TLR ligands (25). Reviewing the
literature led us to speculate that stimulation of NOD2,
a cytosolic NLR of microbial peptidoglycan, may safe-
guard miR-155 activation by bacterial pathogens, as it
can initiate inflammation in endotoxin-tolerant macro-
phages independent of TLR signalling (26). The same
may hold true for NOD1, an NLR that is related to the
NOD2 pathway but senses a different peptidoglycan
residue. Bacterial cell wall peptidoglycan consists of
polymers of N-acetylmuramic acid and N-acetylglu-
cosamides that are linked to each other through short
peptide chains and meso-diaminopimelic acid. The NOD
receptors sense peptidoglycan breakdown products
iE-DAP, which activates NOD1; MDP, which activates
NOD2; and M-TriDAP, which activates both receptors.
To test whether peptodoglycan sensing activates
miR-155 and NFkB activity when TLR signalling is
muted, we rendered the NFkB-reporter containing
RAW264.7 cells endotoxin-tolerant, and challenged
them with the NOD receptor agonists, LPS or both.
Confirming our previous results (25), a challenge of
these endotoxin-tolerant cells with 1 mM of LPS induced
only mild NFkB reporter activity or miR-155 expression,
as compared with naı¨ve cells (Figure 5A and B). Similarly,
stimulation of the NOD1 receptor with its agonist iE-DAP
elicited little, if any, NFkB activity and miR-155 expres-
sion. By contrast, both the NOD1/2 agonist M-TriDAP
and the NOD2 agonist MDP induced significant NFkB
activity and miR-155 expression (Figure 5A and B).
Importantly, co-stimulation of NOD2 with TLR4 by
applying either M-TriDAP or MDP simultaneously with
LPS fully rescued NFkB reporter activity and miR-155
expression (Figure 5A and B). We interpret these obser-
vations to mean that in the context of successful invasion
Figure 5. Analysis of LPS- and peptidoglycan-sensitivity of endotoxin-tolerant (ET) macrophages. (A) NFkB reporter activity on challenge of naı¨ve
and ET RAWBlueTM macrophages with 1000 ng/ml of LPS for 24 h or on challenge of ET RAWBlueTM macrophages with the indicated amounts of
NOD1- and NOD2-stimulating peptidoglycan either alone or in combination with 1000 ng/ml of LPS for 24 h. (B) Similar experiment as in (A) but
measuring miR-155 expression by qRT-PCR in non-transgenic RAW264.7 cells as the final read-out. All results are presented as fold-changes relative
to non-challenged controls (y-axis). Mean values and standard deviations of three independent experiments are shown.
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of endotoxin-tolerant cells by a bacterial pathogen, an
intracellular stimulation of NOD2 restores the TLR4-
based inflammatory response along with the associated
feedback control by miR-155. To the best of our know-
ledge, this is the first demonstration that an miRNA is
additively controlled by different immunostimuli and
NOD-like receptor agonists.
miR-155 also seems to be important for a balanced re-
suscitation of the NFkB response in endotoxin-tolerant
cells. That is, in macrophages with muted LPS response
(Supplementary Figure S3C), ectopic supply of miR-155
(precursor transfection) enhanced the MDP-induced
(i.e. through NOD2 only) NFkB reporter activity, but
limited the full response resulting from the combined
stimulation of NOD2 and TLR4 on simultaneous chal-
lenge with MDP and LPS (Supplementary Figure S3A).
Likewise, inhibition of miR-155 by an antisense LNA had
little effect on reporter induction by LPS or MDP alone
(miR-155 remains suppressed under these conditions), but
it increased NFkB activity on dual challenge with MDP
and LPS (Supplementary Figure S3B).
To address the role of miR-146 in the maintenance of
endotoxin tolerance in macrophages, we inhibited it
before LPS stimulation. Different from inhibition of
miR-155, sequestration of miR-146 significantly elevated
the basal LPS-induced reporter activity (Supplementary
Figure S3B), indicating a role in the maintenance of LPS
hypo-responsiveness in the absence of inflammatory gene
and miR-155 expression. However, over-expression of
miR-146 did not further dampen LPS induced reporter
activity (Supplementary Figure S3A), suggesting that
control by the endogenous miR-146 during tolerance is
saturating. The sum of these observations supports a
dominant role of miR-155 in modulating the inflamma-
tory response on its activation, whereas miR-146 rather
seems to impede inappropriate onset of inflammation.
DISCUSSION
Our results combined with those of previous studies (22)
now support a model of two-tier regulation and division
of labour by two model miRNAs in the macrophage
response to LPS and perhaps other microbial stimuli
(Figure 6). First, we show that despite their general acti-
vation through NFkB, miR-146 and miR-155 are respon-
sive to different thresholds of LPS concentration. Second,
our study of target regulation significantly expands the
notion that miR-146 and miR-155 selectively control
different branches of the TLR4 response. Through target-
ing TAB2, IKKe and NIK, and exerting negative control
of TNF signalling, miR-155 broadly impacts pro-
inflammatory signalling pathways; in contrast, the target-
ing of TLR4 signal transducers TRAF6 and IRAK1
reflects the primary function of miR-146, which is to
control LPS sensing. Accordingly, LPS elicits miR-146
activity in endotoxin-tolerant cells, whereas miR-155
remains mute. Reciprocally, reversal of endotoxin toler-
ance after recognition of intracellular bacteria through
Figure 6. Proposed model of differential miR-155 and miR-146 function in the macrophage response to microbes. Naı¨ve macrophages facing a
microbial LPS trigger utilize miR-146 to prevent TLR4 response to sub-inflammatory doses. In the case of pro-inflammatory LPS doses, miR-155 is
co-induced as a global limiter of the inflammatory response. After withdrawal of an initial microbial stimulus macrophages become refractory to
secondary LPS challenge (endotoxin-tolerant, ET) partly through ongoing negative regulation of TLR-signalling by miR-146 in the absence of
pro-inflammatory response regulator miR-155. Cytosolic microbial PAMP recognition, indicative of pathogenic bacteria, overcomes the miR-146
barrier to inflammation in ET cells and activates inflammation-associated miR-155 both as an initial stimulator and subsequent limiter of the
response.
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NOD2 activates miR-155 to ultimately limit pro-
inflammatory signalling. Thus, although miR-146 may
augment the initial LPS threshold required for mounting
an inflammatory response, miR-155 acts as a final limiter
of pro-inflammatory signalling once the miR-146 barrier
has been breached. Importantly, this division of labour
might also occur on stimulation with PAMPs other than
the TLR4 agonist LPS; when we challenged RAW264.7
macrophages with rising doses of TLR2 inducer BLP,
miR-146 was induced to saturation by much (100
times) lower concentrations than those required to fully
induce miR-155 (Supplementary Figure S4). The sum of
these observations suggests that instead of acting redun-
dantly and simultaneously, miR-146 and miR-155 fulfil
different functions and adjust the lower and upper limits
of the macrophage inflammatory response to microbes.
Precisely what determines the differential activation at
the molecular level remains to be understood. Given the
congruent expression changes of the primary versus
mature form for both miRNAs (Figure 1), the differential
responsiveness to LPS is likely because of transcriptional
rather than processing activity. Interestingly, pre-
stimulation of macrophages with the anti-inflammatory
cytokine IL-10 has recently been demonstrated to
decrease induction of the primary transcript of miR-155,
but not of miR-146a and miR-146b, further supporting
our observation of miR-155, but not miR-146, being
coupled to inflammation (27). A possible explanation for
the differential expression of the miR-146 and miR-155
genes may be non-cooperative and cooperative NFkB
binding sites in their promoter sequences, which have
been reported to mediate differential activation of
NFkB-controlled inflammatory genes (21).
miR-155 closely mimics the gradual induction of most
NFkB-dependent genes in response to environmental
stimuli (Figure 1), which might confer post-transcriptional
control of multiple cellular branches of the pro-inflam-
matory response. For instance, miR-155 reportedly sup-
presses negative regulators of inflammation, such as
SHIP-1, SOCS-1 or PIK3CA (13,28,29), pro-inflamma-
tory signalling components, such as TAB2, IKKe or
FOS (9,29,30), and mediators of programmed cell
death, such as BIRC4BP, FADD or PMAIP1 (5,29,31).
We show that it is also miR-155 and not miR-146 that
negatively regulates the TNF-a signalling pathway,
which sustains LPS-induced NFkB activity through TNF
autocrine feedback (32). Thus, a major function of the
co-induction of miR-155 with classical markers of the
pro-inflammatory response probably is to link this
miRNA to the control of secondary NFkB activation
downstream of LPS. In support of this hypothesis,
miR-155 was recently shown to negatively regulate
chemokine IP-10 expression in response to interferon-g
stimulation of human kidney cells that were co-stimulated
with TNF-a (33).
The selective negative control of TNF-a-induced NFkB
activity may also involve TAB2, which is exclusively
targeted by miR-155 (Figure 4). At the same time,
miR-155 may enhance TNF-a production through stabil-
ization of its messenger (11,14). Thus, the simultaneous
negative regulation of autocrine signalling and positive
regulation of TNF-a production by miR-155 might
favour the activation of bystander macrophages through
TNF paracrine signalling while preventing hyper-
activation of the TNF-producing cell. Other miRNAs
have been reported to counterregulate TNF production,
suggesting that this cytokine is under tight
post-transcriptional control (11,34). Further evidence for
the regulation of pro-inflammatory signalling beyond
TNF-a comes from our confirmation of IKKe as an
miR-155 target (Figure 4); IKKe functions in
TRIF-dependent signalling downstream of TLR4 and
thereby links miR-155 to type I interferon expression.
Moreover, the new miR-155 target NIK phosphorylates
the PU.1 transcription factor downstream of macrophage
activation by LPS to mediate activation of Ptgs2, the
synthase of the pro-inflammatory prostaglandin E2
(PGE2) (10). PU.1 itself is another reported target of
miR-155 (35), suggesting tight control of this pathway
by miRNA. PGE2 functions as an immune hormone
that acts on a broad range of target cells to fuel inflam-
matory gene expression as well as on the central nervous
system to trigger fever and to increase pain-sensitivity.
Our demonstration that IKKe, NIK and TAB2 are select-
ively regulated by miR-155 reveals its specialized function
in the regulation of pro-inflammatory responses over that
of miR-146.
Reciprocally, we show that the known miR-146 targets
in TLR4 signalling, IRAK1 and TRAF6, are not
impacted by miR-155 (Supplementary Figure S2). Our
results demonstrate that miR-146 is induced by sub-
inflammatory LPS levels (Figure 1) and regulates targets
in endotoxin-tolerant macrophages (Supplementary
Figure S3B), which strongly supports the functional spe-
cialization of this miRNA towards maintenance of innate
immune tolerance (17) and LPS hypo-sensitivity (36). In
physiological terms, LPS tolerance is required to limit
uncontrolled immune reactions that might cause loss of
tissue integrity, sepsis, auto-immune diseases or cancer
(37). Maintenance of TLR4-based tolerance to extracel-
lular stimuli (possibly involving miR-146), but it
unabated sensitivity to cell-invasive bacterial pathogens
through NOD2, the cytosolic sensor of microbial pep-
tidoglycan, might limit such harmful immune reactions
while staying fully responsive to enterobacterial attack.
Details of the roles of different NLRs in signalling
cellular immune responses to invading microbes are
only beginning to emerge, and this is the first report of
an miRNA being regulated by an NLR. It will be import-
ant to expand the current analysis of miR-146 and
miR-155 to other cell types of the immune system,
including primary cells, to understand how the differential
activation of miRNAs contributes to the selective recog-
nition of microbial pathogens by signalling through TLRs
and NLRs.
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